Home > Insider Trading > Filing (0001567619-18-006089)

Filing Details

Accession Number:: 0001567619-18-006089
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-14 12:09:50
Reporting Period:: 2018-11-12

Accepted Time:: 2018-11-14 12:09:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722723	Hanger Inc.	HNGR	Services-Specialty Outpatient Facilities, Nec (8093)	840904275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1466989	E Thomas Hartman	10910 Domain Drive Suite 300 Austin TX 78758	Svp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-11-12	302	$20.03	62,408	No	4	F	Direct
Common Stock	Disposition	2018-11-12	2,200	$20.26	60,208	No	4	S	Direct
Common Stock	Disposition	2018-11-13	3,800	$19.67	56,408	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (right to buy)	$12.77		2027-05-19	70,818	70,818	Direct
Common Stock	Performance Share Units	$0.00		2020-05-19	28,327	28,327	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-05-19	70,818	70,818	Direct
2020-05-19	28,327	28,327	Direct

Footnotes

Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
These shares were sold at a range of sale prices from $20.00 to $20.5365. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares were sold at a range of sale prices from $19.50 to $19.95. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Consists of (i) unvested restricted shares and fully vested shares totaling 9,860 shares of stock from an initial grant of 10,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021; (ii) unvested restricted shares totaling 11,147 shares of stock from an initial grant of 11,147 shares of restricted stock that begins to vest on March 9, 2019; (iii) unvested restricted shares and fully vested shares totaling 5,042 shares of stock from an initial grant of 6,359 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 6, 2018 and 2019; (iv) unvested restricted shares and fully vested shares totaling 9,391 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 8, 2018; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 4,353 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (vi) unvested restricted shares and fully vested shares totaling 6,911 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 7, 2017; (vii) unvested restricted shares and fully vested shares totaling 3,977 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (viii) unvested restricted shares and fully vested shares totaling 2,885 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(ix) fully vested shares totaling 764 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014 (x) fully vested shares totaling 878 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; and (xi) fully vested shares totaling 1,200 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.